Clinical Trials on Pasteurellaceae Infections

Total 56358 results

Public Health England

Completed

A Study to Gather Safety Data Following Administration of a Hib-containing Booster Vaccine in Children Aged Two to Five Years (DIPS)

Haemophilus Infections

United Kingdom
Novartis Vaccines

Completed

Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children

Haemophilus Influenzae Type B Infection

Korea, Republic of
Johns Hopkins Bloomberg School of Public Health
Merck Sharp & Dohme LLC

Completed

Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)

Haemophilus Influenzae Type B Infection

United States
St. Petersburg Research Institute of Vaccines and...

Completed

Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b

Vaccines | Haemophilus Influenzae Infection

Russian Federation
Novartis Vaccines

Completed

Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China

Haemophilus Influenzae Type b (Hib) Infection

China
Beijing Minhai Biotechnology Co., Ltd

Unknown

Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried

Haemophilus Influenzae Type b Infections

China
Sanofi Pasteur, a Sanofi Company

Completed

Retrospective Survey of Safety of Fourth Dose Pentacel® in Children

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infection

Canada
Sanofi

Completed

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infection

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b

Haemophilus Influenzae Type b

China
Aga Khan University
University of British Columbia; Grand Challenges Canada

Unknown

Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan

Hepatitis B | Pertussis | Tetanus | Diphtheria | Tuberculosis | Polio | Pneumococcal Infection | Haemophilus Influenzae Type b Infection
Jiangsu Province Centers for Disease Control and...
Chengdu Olymvax Biopharmaceuticals Inc.

Completed

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus Influenza
Jiangsu Province Centers for Disease Control and...
Royal (Wuxi) Biological Co., LTD

Completed

Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children

Group A, C Polysaccharide Meningitis | Type b Haemophilus Influenza

China
Novartis Vaccines

Completed

Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b

Haemophilus Influenzae Type b

China
GlaxoSmithKline

Completed

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b

Australia
Sanofi Pasteur, a Sanofi Company

Completed

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infections

United States
Centers for Disease Control and Prevention
Bill and Melinda Gates Foundation; Ministry of Health, Uganda; African Field... and other collaborators

Completed

Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda

Hepatitis B | Measles | Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Influenzae Type b Infection
Sanofi

Completed

Immunogenicity and Safety of Pentaxim™ in an Indian Population

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infections

India
GlaxoSmithKline

Completed

Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b | Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine

Poland, United Kingdom
LG Chem

Unknown

A Phase IV Study to Assess the Safety of EupentaTM Inj

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type B Infection
LG Chem

Not yet recruiting

A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b Infection
LG Chem

Completed

A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b Infection

Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b Infection

Korea, Republic of
Sanofi

Completed

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Infections

Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Infections

Philippines
GiveWell
New Incentives; All Babies are Equal Initiative

Completed

Evaluation of an Infant Immunization Encouragement Program in Nigeria

Hepatitis B | Measles | Pertussis | Tetanus | Diphtheria | Tuberculosis | Pneumonia, Bacterial | Yellow Fever | Polio | Rotavirus Infections | Haemophilus Influenzae Type b Infection

Nigeria
Sanofi

Completed

Immunogenicity and Safety of Pentaxim in South African Infants

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Infections

South Africa
LG Chem

Not yet recruiting

Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type B Infection
Sanofi Pasteur, a Sanofi Company

Completed

Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type B Infection

Mexico
Crucell Holland BV

Completed

A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Infections

Philippines
Crucell Holland BV

Completed

Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Infections

Philippines
LG Chem

Unknown

Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b Infection
Crucell Holland BV

Completed

Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Infections

Vietnam
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Hepatitis B | Measles | Pertussis | Rubella | Mumps | Tetanus | Diphtheria | Varicella | Poliomyelitis | Haemophilus Infections

Germany, Italy
Pfizer

Completed

Post-Authorization Study Evaluating Safety Of Tigecycline (HORUS)

Intra-Abdominal Infections | Skin Disease, Infectious | Soft Tissues Infections
Kirby Institute

Not yet recruiting

PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised. (PATH)

Invasive Fungal Infections | Infection, Bacterial | Infection, Fungal | Injection Site Infection | Infection, Soft Tissue | Invasive Bacterial Infection
Johns Hopkins Bloomberg School of Public Health

Completed

Etiology, Prevention and Treatment of Neonatal Infections in the Community

Infectious Disease | Bacterial Infection

Bangladesh
Mayo Clinic
Ortho-McNeil, Inc.

Completed

The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection

Staphylococcal Infection | Staphylococcus Aureus Prosthetic Joint Infection

United States
University Hospital, Strasbourg, France

Recruiting

Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg (CARBA)

Nfections, Enterobacterial

France
Hospices Civils de Lyon

Completed

Staphylococcus Lugdunensis Prosthetic Joint Infection

Staphylococcal Infections | Prosthetic Joint Infection

France
Orlando Health, Inc.
Forest Laboratories

Withdrawn

Ceftaroline in the Treatment of Bone and Joint Infections

Osteomyelitis | Joint Infections

United States
Adaptive Phage Therapeutics, Inc.

Withdrawn

Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections (ACTIVE1)

Bacterial Infections | Prosthetic Joint Infection
Hospices Civils de Lyon

Completed

Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection

Bacterial Infections | Bone and Joint Infection | EPIDEMIOLOGY
University Hospital, Strasbourg, France

Unknown

Cliavist in Infectious and Degenerative Diseases of the Spine

Spine Infection

France
University Hospital, Brest
Centre de Référence des Infections Ostéo-Articulaires du Grand Ouest

Completed

Retrospective Study of Bone Infection Due to Campylobacter Spp (CAMPYLO)

Bone Diseases, Infectious | Campylobacter Infections

France
Hospices Civils de Lyon

Completed

Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration

Staphylococcus Aureus | Bone and Joint Infection | Teicoplanin-based Antimicrobial Therapy

France
Assistance Publique Hopitaux De Marseille

Completed

Value of Flow Cytometry in Infectious Point of Care: Feasibility Study

A Potential Infectious Respiratory Clinical Syndrome | Potential Clinical Urinary Infectious Syndrome | A Potential Clinical Abdominal Infection Syndrome

France
Red Queen Therapeutics, Inc.
PPD

Completed

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

COVID-19 | Infectious Disease | SARS CoV 2 Infection | Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
Frieder Schaumburg

Not yet recruiting

Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial (SoTiClin)

Staphylococcal Infections | Staphylococcus Aureus Infection | Skin Infection
Assistance Publique Hopitaux De Marseille

Completed

Causative Diagnosis on Prosthetic Joint Infections: Establishment of a Comprehensive Diagnostic Strategy

Prosthetic Joint Infections

France

Clinical Trials on Pasteurellaceae Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations